10x Genomics, Fred Hutch launch clinical research collaboration on single-cell, spatial oncology applications

• 10x Genomics launched a clinical research collaboration with Fred Hutch to extend its oncology evidence base into blood cancers.
• Bladder cancer work will study whether single-cell and spatial readouts can predict treatment response, aiming to support future therapy selection.
• A separate acute myeloid leukemia project will test whether single-cell analysis can improve residual disease detection versus today’s fragmented approach.
• No clinical results were reported; findings are expected in future readouts as the studies progress.
• Effort supports groundwork for potential diagnostic use, including a clinical reporting framework tied to 10x’s planned CLIA-certified lab.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 10x Genomics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610070900PR_NEWS_USPR_____LA65153) on October 07, 2026, and is solely responsible for the information contained therein.